Cibus CBUS 深 沪
交易中 09-20 15:30:21 美东时间
3.985
+0.105
+2.71%
华盛通- 最 高4.035
- 今 开3.80
- 成交量 29.20万股
- 最 低 3.58
- 昨 收 3.88
- 总市值 7478.53万
- 52周最高 23.18
- 市盈率 静 --
- 换手率 1.56%
- 52周最低 3.58
- 委 比 -99.36%
- 总股本 1876.67万
- 历史最高 1594.50
- 量 比 0.50
- 振 幅 11.73%
- 历史最低 3.58
- 每 手 1
- 风险率 4.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Expert Ratings For Cibus
Providing a diverse range of perspectives from bullish to bearish, 4 analysts h...
09-20 03:03
Why Cibus (CBUS) Stock Is Down 21% Wednesday
Cibus shares are trading lower by 23% Wednesday morning. The company announced a $12 million offering of 3 million shares priced at $4.00 each.
09-18 22:25
Cibus Q1 2024 GAAP EPS $(1.12) Up From $(5.46) YoY, Sales $545.000K Up From $42.000K YoY
Cibus (NASDAQ:CBUS) reported quarterly losses of $(1.12) per share. This is a 79.49 percent increase over losses of $(5.46) per share from the same period last year. The company reported $545.000 thousand in sales this
05-10 06:20
Earnings Scheduled For March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
03-21 18:15
Cibus Announces Registered Direct Offering of 2.1M Shares at $9.00/Share
Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that it has priced an underwritten offering of 2,106,723 shares of its Class
2023-12-12 20:32
Cibus Announces New Publication: Industrial Scale Gene Editing In Brassica Napus
In the peer reviewed publication, the International Journal of Plant Biology, Cibus provides two case studies of improving oleic oil content and developing pod shatter reduction in Brassica napus (canola,
2023-11-30 21:02
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
2023-11-09 19:52
HC Wainwright & Co. Reiterates Buy on Cibus, Maintains $25 Price Target
HC Wainwright & Co. analyst Amit Dayal reiterates Cibus (NASDAQ:CBUS) with a Buy and maintains $25 price target.
2023-10-09 18:35
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers First Wave BioPharma (NASDAQ:FWBI) stock increased by 136.2% to $0.69 ...
2023-09-06 01:31
Cibus Q2 EPS $0.30, Sales $203.31M
Cibus (NASDAQ:CBUS) reported quarterly earnings of $0.30 per share. The company reported $203.31 million in sales this quarter.
2023-08-10 05:22
